{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:42:23Z","timestamp":1790660543636,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.lansea.2026.100746","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T10:26:46Z","timestamp":1772533606000},"page":"100746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunogenicity and safety of Biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14\u00ae) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trial"],"prefix":"10.1016","volume":"46","author":[{"given":"Subhash","family":"Thuluva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh V.","family":"Matur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbareddy","family":"Gunneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddalingaiah","family":"Ningaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4192-3760","authenticated-orcid":false,"given":"Vijay","family":"Yerroju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6638-7701","authenticated-orcid":false,"given":"Rammohan Reddy","family":"Mogulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7614-4026","authenticated-orcid":false,"given":"Kamal","family":"Thammireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-077X","authenticated-orcid":false,"given":"Anand","family":"Kawade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Nanjappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jog","family":"Pramod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-0797","authenticated-orcid":false,"given":"Manish","family":"Narang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bheemisetty S.","family":"Chakravarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanth M.","family":"Virupakashappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lansea.2026.100746_bib1","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.lansea.2026.100746_bib2","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/S1473-3099(22)00510-2","article-title":"Age\u2013sex differences in the global burden of lower respiratory infections and risk factors, 1990\u20132019: results from the Global Burden of Disease Study 2019","volume":"22","author":"Kyu","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"10.1016\/j.lansea.2026.100746_bib3","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"43","key":"10.1016\/j.lansea.2026.100746_bib4","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1016\/j.vaccine.2017.09.005","article-title":"The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: a systematic review and meta-analysis","volume":"35","author":"Alicino","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.lansea.2026.100746_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1473-3099(24)00665-0","article-title":"Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis","volume":"25","author":"Bennett","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.lansea.2026.100746_bib6","doi-asserted-by":"crossref","first-page":"60.e9","DOI":"10.1016\/j.cmi.2015.08.027","article-title":"Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA","volume":"22","author":"Metcalf","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.lansea.2026.100746_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lansea.2026.100746_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108617","article-title":"Distribution of serotypes, vaccine coverage, and antimicrobial susceptibility pattern of Streptococcus pneumoniae in children living in SAARC countries: a systematic review","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.lansea.2026.100746_bib9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s13312-018-1398-x","article-title":"Non-vaccine pneumococcal serotypes among children with invasive pneumococcal disease","volume":"55","author":"John","year":"2018","journal-title":"Indian Pediatr"},{"issue":"37","key":"10.1016\/j.lansea.2026.100746_bib10","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.15585\/mmwr.mm7137a3","article-title":"Use of 15-valent pneumococcal conjugate vaccine among U.S. children: updated recommendations of the Advisory Committee on Immunization Practices-United States, 2022","volume":"71","author":"Kobayashi","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"39","key":"10.1016\/j.lansea.2026.100746_bib11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.15585\/mmwr.mm7239a5","article-title":"ACIP updates: recommendations for use of 20-valent pneumococcal conjugate vaccine in children\u2014United States, 2023","volume":"72","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"10.1016\/j.lansea.2026.100746_bib12","first-page":"173","article-title":"Pneumococcal vaccines: WHO position paper \u2013 2023 update","volume":"98","year":"2023","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lansea.2026.100746_bib13","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/INF.0000000000000076","article-title":"Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers","volume":"33 Suppl 2","author":"Whitney","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.lansea.2026.100746_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/cid\/ciae377","article-title":"Assessing the impact of pneumococcal conjugate vaccine immunization schedule change from 3+0 to 2+1 in Australian children: a retrospective observational study","volume":"80","author":"Jayasinghe","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lansea.2026.100746_bib15","series-title":"Vaccination Schedule for Pneumococcal Disease","year":"2025"},{"issue":"13","key":"10.1016\/j.lansea.2026.100746_bib16","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.vaccine.2024.03.056","article-title":"Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14\u2122) administered to 6\u20138 weeks old healthy Indian infants: a single blind, randomized, active-controlled, phase III study","volume":"42","author":"Matur","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.lansea.2026.100746_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1550227","article-title":"Immunogenicity and safety of a multi-human dose formulation of biological E's 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14\u00ae) administered to 6\u20138-week-old healthy infants: a phase 3, single-blind, randomized, active-controlled study","volume":"16","author":"Thuluva","year":"2025","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.lansea.2026.100746_bib18","first-page":"514","article-title":"Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides","volume":"10","author":"Wernette","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.lansea.2026.100746_bib19","series-title":"Recommendations to Assure the Quality, Safety and Efficacy of Pneumococcal Conjugate Vaccines. Annex 3, WHO Technical Report Series No. 977","year":"2013"},{"issue":"12","key":"10.1016\/j.lansea.2026.100746_bib20","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.lansea.2026.100746_bib21","year":"2019"},{"issue":"4","key":"10.1016\/j.lansea.2026.100746_bib22","first-page":"755","article-title":"Pneumococcal serotype evolution and vaccine impact: analysis of invasive pneumococcal disease in the United States, 2010\u20132018","volume":"71","author":"Chochua","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.lansea.2026.100746_bib23","first-page":"539","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.lansea.2026.100746_bib24","first-page":"235","article-title":"Epidemiology and serotype distribution of invasive pneumococcal disease in children and adults in Canada, 2010\u20132016","volume":"44","author":"Tsang","year":"2018","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.lansea.2026.100746_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126692","article-title":"A comprehensive analysis of serotype-specific invasive capacity, clinical presentations, and mortality trends of invasive pneumococcal disease","volume":"47","author":"Yildirim","year":"2025","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.lansea.2026.100746_bib26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/322984","article-title":"Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants","volume":"184","author":"V\u00e4kev\u00e4inen","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.lansea.2026.100746_bib27","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/INF.0000000000000079","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity","volume":"33Suppl 2","author":"Deloria Knoll","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"9862","key":"10.1016\/j.lansea.2026.100746_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.lansea.2026.100746_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1017\/S0950268812000763","article-title":"Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England","volume":"141","author":"Chapman","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"10","key":"10.1016\/j.lansea.2026.100746_bib30","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"36","key":"10.1016\/j.lansea.2026.100746_bib31","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.lansea.2026.100746_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.vaccine.2020.11.018","article-title":"Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands","volume":"39","author":"Peckeu","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.lansea.2026.100746_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children-a population-based study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.lansea.2026.100746_bib34","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.vaccine.2020.01.062","article-title":"Impact of HIV status and vaccination schedule on bacterial nasopharyngeal carriage following infant immunisation with the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in South Africa","volume":"38","author":"Madhi","year":"2020","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.lansea.2026.100746_bib35","first-page":"411","article-title":"WHO position paper: pneumococcal conjugate vaccines in infants and children aged <5 years \u2013 September 2025","volume":"100","year":"2025","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.lansea.2026.100746_bib36","article-title":"Safety and immunogenicity of biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14\u00ae) administered in a 3p+ 1 schedule to healthy Indian infants and toddlers: a prospective, multicenter, active controlled phase IV trial","author":"Thuluva","year":"2025","journal-title":"medRxiv"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226000314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368226000314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:27:58Z","timestamp":1773394078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368226000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"alternative-id":["S2772368226000314"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100746","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of Biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14\u00ae) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2026.100746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100746"}}